- Home
- SNGX vs CVR Comparison
SNGX vs CVR Comparison
Compare SNGX & CVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- CVR
- Stock Information
- Founded
- SNGX 1987
- CVR 1920
- Country
- SNGX United States
- CVR United States
- Employees
- SNGX N/A
- CVR N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- CVR Industrial Machinery/Components
- Sector
- SNGX Health Care
- CVR Industrials
- Exchange
- SNGX Nasdaq
- CVR Nasdaq
- Market Cap
- SNGX 10.1M
- CVR 9.8M
- IPO Year
- SNGX 1987
- CVR N/A
- Fundamental
- Price
- SNGX $2.92
- CVR $9.80
- Analyst Decision
- SNGX Strong Buy
- CVR
- Analyst Count
- SNGX 1
- CVR 0
- Target Price
- SNGX $6.00
- CVR N/A
- AVG Volume (30 Days)
- SNGX 10.0M
- CVR 2.4K
- Earning Date
- SNGX 11-07-2025
- CVR 11-11-2025
- Dividend Yield
- SNGX N/A
- CVR 1.22%
- EPS Growth
- SNGX N/A
- CVR N/A
- EPS
- SNGX N/A
- CVR N/A
- Revenue
- SNGX N/A
- CVR $25,617,681.00
- Revenue This Year
- SNGX N/A
- CVR N/A
- Revenue Next Year
- SNGX N/A
- CVR N/A
- P/E Ratio
- SNGX N/A
- CVR N/A
- Revenue Growth
- SNGX N/A
- CVR N/A
- 52 Week Low
- SNGX $1.09
- CVR $8.15
- 52 Week High
- SNGX $6.23
- CVR $22.27
- Technical
- Relative Strength Index (RSI)
- SNGX 51.64
- CVR 39.76
- Support Level
- SNGX $2.58
- CVR $8.97
- Resistance Level
- SNGX $3.11
- CVR $10.56
- Average True Range (ATR)
- SNGX 0.22
- CVR 0.29
- MACD
- SNGX -0.09
- CVR 0.04
- Stochastic Oscillator
- SNGX 43.59
- CVR 36.40
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About CVR Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.